Abstract:
Biomedical engineering is rooted in engineering principles and leverages advancements in biology to address unmet clinical needs. Recent breakthroughs in stem cell technology, genetic manipulation, and cell and developmental biology have provided engineers with unprecedented opportunities to tackle major challenges facing our aging society, including neurodegeneration, diabetes, cancer, and tissue and organ regeneration.
In this talk, I will provide an overview of our research activities in biomedical engineering and medical biotechnology at the University of Oxford and the Oxford Suzhou Centre for Advanced Research. I will also share my experience in commercializing innovative technologies, including 3D cell culture, bioreactor technology, and rapid COVID-19 testing. Additionally, I will discuss the challenges of technology transfer in medical engineering and biotechnology, highlighting the critical role of interdisciplinary collaboration.
SPEAKERS / PERFORMERS:
Zhanfeng CUI
The Donald Pollock Professor of Chemical Engineering at the University of Oxford, the Founding Director of the Oxford Suzhou Centre for Advanced Research (OSCAR), a Fellow of the Royal Academy of Engineering (FREng), a Foreign Member of the Chinese Academy of Engineering, a Fellow of the UK Academy of Medical Sciences.
Professor Zhanfeng CUI is the Donald Pollock Professor of Chemical Engineering, University of Oxford since the Chair was established in 2000. He is the Founding Director of the Oxford Suzhou Centre for Advanced Research (OSCAR), the only Oxford University Centre outside the UK in Physical Sciences and Engineering. He was educated in China, and awarded BSc (1982), from Inner Mongolia Polytechnic University, MSc (1984) and PhD (1987) from Dalian University of Technology. After being a postdoc in Strathclyde University (1988-1991), he became a Lecturer of Chemical Engineering in Edinburgh University in 1991, moved to Oxford in 1994 as a University Lecturer in Engineering Science and Tutorial Fellow of Keble College. He became a Reader in Engineering Science in 1999. He was elected to the first Chemical Engineering Chair at the University of Oxford in 2000 and a Professorial Fellow of Hertford College. He is a Fellow of the Institution of Chemical Engineers (FIChemE, 2003) and a Fellow of American Institute of Medical and Biological Engineering (FAIMBE, 2014). In 2009, he was awarded a Higher Doctorate, Doctor of Science (DSc), by the University of Oxford, to recognize his excellence in academic scholarship. He was elected to a Fellow of the Royal Academy of Engineering (FREng) in 2013, a Foreign Member of the Chinese Academy of Engineering in 2021, and a Fellow of the UK Academy of Medical Sciences (FMedSci) in 2023. Prof CUI’s research lies on the interface between Chemical Engineering and Life Sciences and Medicine. His current research interests focus on the development of enabling technologies for regenerative medicine (bioreactors, three dimensional culture, cryopreservation and scale-up), and applications to treat cancers, diabetes, neural degeneration and musculoskeletal conditions. He is also active in developing in vitro diagnostic technologies for point of care testing, in particular, of cancers and infectious diseases. Prof CUI is an Editor-in-Chief of Bio-Design and Manufacturing.
Language:
English
Registration: